Eurlex法規(guī)編號(hào): |
(EU) 2024/2781 |
OJ編號(hào): |
OJ L, 2024/2781, 4.11.2024 |
中文標(biāo)題: |
2024年10月31日委員會(huì)實(shí)施條例(EU) 2024/2781:修訂實(shí)施條例(EU) No 540/2011,關(guān)于延長(zhǎng)活性物質(zhì)8-羥基喹啉,、氨基吡唑啉,、嘧菌酯、嗜油假絲酵母菌株O,、氯蟲苯甲酰苯胺,、氟啶、抑霉唑,、甲基克雷松,、甲溴脲、氟草醚,、伏馬玫瑰擬青霉FE 9901菌株,、特氟氯氰菊酯和特丁基鋅的批準(zhǔn)期 |
原文標(biāo)題: |
Commission Implementing Regulation (EU) 2024/2781 of 31 October 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 8-hydroxyquinoline, aminopyralid, azoxystrobin, Candida oleophila strain O, chlorantraniliprole, fluroxypyr, imazalil, kresoxim-methyl, metobromuron, oxyfluorfen, Paecilomyces fumosoroseus strain FE 9901, tefluthrin and terbuthylazine |
發(fā)布日期 |
2024-11-04 |
原文鏈接 |
查看歐盟官網(wǎng)文件 |
閱讀:369次